The association between antiretroviral therapy and early placental function: a cohort study

References

• Public Health Agency of Canada. HIV and AIDS in Canada: surveillance report to December 31, 2014. Ottawa: Minister of Public Works and Government Services Canada; 2015.
   Google Scholar
• Siegfried N, van der Merwe L, Brocklehurst P, et al. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2011;7:CD003510.
   Google Scholar
• Loutfy MR, Margolese S, Money DM, et al. Canadian HIV pregnancy planning guidelines. Int J Gynaecol Obstet. 2012;119:89–99.
   PubMed Web of Science ®Google Scholar
• Charlton TG, Franklin JM, Douglas M, et al. The impact of HIV infection and antiretroviral therapy on the predicted risk of Down syndrome. Prenat Diagn. 2014;34:121–127.
   PubMed Web of Science ®Google Scholar
• Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. BJOG. 1998;105:836–848.
   Web of Science ®Google Scholar
• Wedi CO, Kirtley S, Hopewell S, et al. Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis. Lancet HIV. 2016;3:e33–e48.
   PubMed Web of Science ®Google Scholar
• Lopez M, Figueras F, Hernandez S, et al. Association of HIV infection with spontaneous and iatrogenic preterm delivery: effect of HAART. AIDS. 2012;26:37–43.
   PubMed Web of Science ®Google Scholar
• Chen JY, Ribaudo HJ, Souda S, et al. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis. 2012;206:1695–1705.
   PubMed Web of Science ®Google Scholar
• Li N, Sando MM, Spiegelman D, et al. Antiretroviral therapy in relation to birth outcomes among HIV-infected women: a cohort study. J Infect Dis. 2016;213:1057–1064.
   PubMed Web of Science ®Google Scholar
• Alemu FM, Yalew AW, Fantahun M, et al. Antiretroviral therapy and pregnancy outcomes in developing countries: a systematic review. Int J MCH AIDS. 2015;3:31–43.
   PubMedGoogle Scholar
• Papp E, Mohammadi H, Loutfy MR, et al. HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction. J Infect Dis. 2015;211:10–18.
   PubMed Web of Science ®Google Scholar
• Suy A, Martínez E, Coll O, et al. Increased risk of preeclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS. 2006;20:59–66.; English.
   PubMed Web of Science ®Google Scholar
• Wimalasundera RC, Larbalestier N, Smith JH, et al. Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet. 2002;360:1152–1154.
   PubMed Web of Science ®Google Scholar
• Sansone M, Sarno L, Saccone G, et al. Risk of preeclampsia in human immunodeficiency virus–infected pregnant women. Obstet Gynecol. 2016;127:1027–1032.
   PubMed Web of Science ®Google Scholar
• Einstein FH, Wright RL, Trentacoste S, et al. The impact of protease inhibitors on maternal serum screening analyte levels in pregnant women who are HIV positive. Am J Obstet Gynecol. 2004;191:1004–1008.
   PubMed Web of Science ®Google Scholar
• Le Meaux JP, Tsatsaris V, Schmitz T, et al. Maternal biochemical serum screening for Down syndrome in pregnancy with human immunodeficiency virus infection. Obstet Gynecol. 2008;112:223–230.
   PubMed Web of Science ®Google Scholar
• Gross S, Castillo W, Crane M, et al. Maternal serum α-fetoprotein and human chorionic gonadotropin levels in women with human immunodeficiency virus. Am J Obstet Gynecol. 2003;188:1052–1056.
   PubMed Web of Science ®Google Scholar
• Ackerman W, Kwiek JJ. Role of the placenta in adverse perinatal outcomes among HIV-1 seropositive women. J Nippon Med Sch. 2013;80:90–94.
   PubMed Web of Science ®Google Scholar
• Money D, Tulloch K, Boucoiran I, et al. Guidelines for the care of pregnant women living with HIV and interventions to reduce perinatal transmission: executive summary. J Obstet Gynaecol Can. 2014;36:721–734.
   PubMedGoogle Scholar
• Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services; 2016.
   Google Scholar
• World Health Organization [Internet]. HIV/AIDS Key facts 2018; March 19, 2018. [cited 2018 Dec 12]. Available from: http://www.who.int/news-room/fact-sheets/detail/hiv-aids.
   Google Scholar
• Burdge DR, Money DM, Forbes JC, et al. Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines). CMAJ. 2003;168:1671–1674.
   PubMed Web of Science ®Google Scholar
• Hegazi A, Mc Keown D, Doerholt K, et al. Raltegravir in the prevention of mother-to-child transmission of HIV-1: effective transplacental transfer and delayed plasma clearance observed in preterm neonates. AIDS 2012;26:2421–2423.
   PubMed Web of Science ®Google Scholar
• Schalkwijk S, Greupink R, Colbers AP, et al. Placental transfer of the HIV integrase inhibitor dolutegravir in an ex vivo human cotyledon perfusion model. J Antimicrob Chemother. 2016;71:480–483.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, et al. Research Electronic Data Capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.
   PubMed Web of Science ®Google Scholar
• Lambert-Messerlian G, Palomaki GE, Canick JA. Examination of the pregnancy-associated plasma protein-A assay on the Beckman Coulter Access® platform: suitability for use in first trimester Down’s syndrome screening. J Med Screen. 2010;17:109–113.
   PubMed Web of Science ®Google Scholar
• Kagan KO, Wright D, Spencer K, et al. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol. 2008;31:493–502.
   PubMed Web of Science ®Google Scholar
• Madsen HN, Ekelund CK, Tørring N, et al. Impact of type 1 diabetes and glycemic control on fetal aneuploidy biochemical markers. Acta Obstet Gynecol Scand. 2012;91:57–61.
   PubMed Web of Science ®Google Scholar
• Spencer K, Bindra R, Nicolaides KH. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn. 2003;23:851–855.
   PubMed Web of Science ®Google Scholar
• Spencer K, Ong CYT, Liao AWJ, et al. The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities. Prenat Diagn. 2000;20:491–494.
   PubMed Web of Science ®Google Scholar
• Spencer K. The influence of fetal sex in screening for Down syndrome in the second trimester using AFP and free β-hCG. Prenat Diagn. 2000;20:648–651.
   PubMed Web of Science ®Google Scholar
• Reynolds TM, Vranken G, Van Nueten J. Weight correction of MoM values: which method?. J Clin Pathol. 2006;59:753–758.
   PubMed Web of Science ®Google Scholar
• Wald NJ, Kennard A, Hackshaw A, et al. Antenatal screening for Down’s syndrome. J Med Screen. 1997;4:181–246.
   PubMedGoogle Scholar
• Chougrani I, Muller F, Marcelin L, et al. Combined first-trimester Down syndrome screening in HIV-infected women. Eur J Obstet Gynecol Reprod Biol. 2016;203:274–278.
   PubMed Web of Science ®Google Scholar
• Savvidou MD, Samuel I, Syngelaki A, et al. First-trimester markers of aneuploidy in women positive for HIV. BJOG. 2011;118:844–848.
   PubMed Web of Science ®Google Scholar
• Brossard P, Boulvain M, Coll O, et al. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study. AIDS 2008;22:2013–2017.
   PubMed Web of Science ®Google Scholar
• Yudin MH, Prosen TL, Landers DV. Multiple-marker screening in human immunodeficiency virus–positive pregnant women: screen positivity rates with the triple and quad screens. Am J Obstet Gynecol. 2003;189:973–976.
   PubMed Web of Science ®Google Scholar
• Polliotti BM, Gnall-Sazenski S, Laughlin TS, et al. Inhibitory effects of human chorionic gonadotropin (hCG) preparations on HIV infection of human placenta in vitro. Placenta. 2002;23:S102–S106.
   PubMed Web of Science ®Google Scholar
• Lin J, Lojun S, Lei ZM, et al. Lymphocytes from pregnant women express human chorionic gonadotropin/luteinizing hormone receptor gene. Mol Cell Endocrinol. 1995;111:R13–R17.
   PubMed Web of Science ®Google Scholar
• Conover CA, Bale LK, Overgaard MT, et al. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 2004;131:1187–1194.
   PubMed Web of Science ®Google Scholar
• Gagnon A, Douglas Wilson RD, Audibert F, et al. Complications obstétricales associées aux analytes anormaux des marqueurs sériques maternels. J Obstet Gynaecol Can. 2008;30:933–949.
   Google Scholar
• Geyl C, Subtil D, Vaast P, et al. Interprétation des valeurs atypiques des marqueurs sériques. J Gynecol Obstet Biol Reprod. 2014;43:5–11.
   PubMedGoogle Scholar
• Mizejewski GJ. Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states. Obstet Gynecol Surv. 2003;58:804–826.
   PubMed Web of Science ®Google Scholar
• Duc-Goiran P, Mignot TM, Robert B, et al. Expression and localization of alpha-fetoprotein mRNA and protein in human early villous trophoblasts. Placenta 2006;27:812–821.
   PubMed Web of Science ®Google Scholar
• Newby D, Dalgliesh G, Lyall F, et al. Alphafetoprotein and alphafetoprotein receptor expression in the normal human placenta at term. Placenta 2005;26:190–200.
   PubMed Web of Science ®Google Scholar
• Mizejewski GJ. Alpha-fetoprotein structure and function: relevance to isoforms, epitopes, and conformational variants. Exp Biol Med (Maywood). 2001;226:377–408.
   PubMed Web of Science ®Google Scholar
• Schulte J, Dominguez K, Sukalac T, et al. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: pediatric Spectrum of HIV Disease, 1989–2004. Pediatrics 2007;119:e900–e906.
   PubMed Web of Science ®Google Scholar
• Spencer KK. First and second trimester markers of fetal aneuploidy in pregnant women with HIV infection. Fetal Diagn Ther. 2011;29:135–138.
   PubMed Web of Science ®Google Scholar
• Balogun KA, Guzman Lenis MS, Papp E, et al. Elevated Levels of Estradiol in Human Immunodeficiency Virus-Infected Pregnant Women on Protease Inhibitor-Based Regimens. Clin Infect Dis. 2018;66:420–427.
   PubMed Web of Science ®Google Scholar